183 related articles for article (PubMed ID: 31183633)
21. The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation.
Gu Y; Lv F; Xue M; Chen K; Cheng C; Ding X; Jin M; Xu G; Zhang Y; Wu Z; Zheng L; Wu Y
J Exp Clin Cancer Res; 2018 Oct; 37(1):258. PubMed ID: 30359286
[TBL] [Abstract][Full Text] [Related]
22. Reduced NR4A gene dosage leads to mixed myelodysplastic/myeloproliferative neoplasms in mice.
Ramirez-Herrick AM; Mullican SE; Sheehan AM; Conneely OM
Blood; 2011 Mar; 117(9):2681-90. PubMed ID: 21205929
[TBL] [Abstract][Full Text] [Related]
23. Silencing of MYCN by RNA interference induces growth inhibition, apoptotic activity and cell differentiation in a neuroblastoma cell line with MYCN amplification.
Nara K; Kusafuka T; Yoneda A; Oue T; Sangkhathat S; Fukuzawa M
Int J Oncol; 2007 May; 30(5):1189-96. PubMed ID: 17390021
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-203 inhibits the malignant progression of neuroblastoma by targeting Sam68.
Zhao D; Tian Y; Li P; Wang L; Xiao A; Zhang M; Shi T
Mol Med Rep; 2015 Oct; 12(4):5554-60. PubMed ID: 26136151
[TBL] [Abstract][Full Text] [Related]
25. The NR4A orphan nuclear receptors: mediators in metabolism and diseases.
Ranhotra HS
J Recept Signal Transduct Res; 2015 Apr; 35(2):184-8. PubMed ID: 25089663
[TBL] [Abstract][Full Text] [Related]
26. Nuclear NR4A3 Immunostaining Is a Specific and Sensitive Novel Marker for Acinic Cell Carcinoma of the Salivary Glands.
Haller F; Skálová A; Ihrler S; Märkl B; Bieg M; Moskalev EA; Erber R; Blank S; Winkelmann C; Hebele S; Baněčková M; Wiemann S; Müller S; Zenk J; Eils R; Iro H; Hartmann A; Agaimy A
Am J Surg Pathol; 2019 Sep; 43(9):1264-1272. PubMed ID: 31094928
[TBL] [Abstract][Full Text] [Related]
27. Role of local muscle contractile activity in the exercise-induced increase in NR4A receptor mRNA expression.
Kawasaki E; Hokari F; Sasaki M; Sakai A; Koshinaka K; Kawanaka K
J Appl Physiol (1985); 2009 Jun; 106(6):1826-31. PubMed ID: 19359610
[TBL] [Abstract][Full Text] [Related]
28. Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological features.
Tajiri T; Liu X; Thompson PM; Tanaka S; Suita S; Zhao H; Maris JM; Prendergast GC; Hogarty MD
Clin Cancer Res; 2003 Aug; 9(9):3345-55. PubMed ID: 12960121
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic silencing of the NR4A3 tumor suppressor, by aberrant JAK/STAT signaling, predicts prognosis in gastric cancer.
Yeh CM; Chang LY; Lin SH; Chou JL; Hsieh HY; Zeng LH; Chuang SY; Wang HW; Dittner C; Lin CY; Lin JM; Huang YT; Ng EK; Cheng AS; Wu SF; Lin J; Yeh KT; Chan MW
Sci Rep; 2016 Aug; 6():31690. PubMed ID: 27528092
[TBL] [Abstract][Full Text] [Related]
30.
Dzieran J; Rodriguez Garcia A; Westermark UK; Henley AB; Eyre Sánchez E; Träger C; Johansson HJ; Lehtiö J; Arsenian-Henriksson M
Proc Natl Acad Sci U S A; 2018 Feb; 115(6):E1229-E1238. PubMed ID: 29374092
[TBL] [Abstract][Full Text] [Related]
31. CTCF cooperates with noncoding RNA MYCNOS to promote neuroblastoma progression through facilitating MYCN expression.
Zhao X; Li D; Pu J; Mei H; Yang D; Xiang X; Qu H; Huang K; Zheng L; Tong Q
Oncogene; 2016 Jul; 35(27):3565-76. PubMed ID: 26549029
[TBL] [Abstract][Full Text] [Related]
32. Functional association of NR4A3 downregulation with impaired differentiation in myeloid leukemogenesis.
Lin SC; Yao CY; Hsu CA; Lin CT; Calkins MJ; Kuo YY; Tang JL; Tien HF; Wu SJ
Ann Hematol; 2022 Oct; 101(10):2209-2218. PubMed ID: 36040481
[TBL] [Abstract][Full Text] [Related]
33. Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands.
Haller F; Bieg M; Will R; Körner C; Weichenhan D; Bott A; Ishaque N; Lutsik P; Moskalev EA; Mueller SK; Bähr M; Woerner A; Kaiser B; Scherl C; Haderlein M; Kleinheinz K; Fietkau R; Iro H; Eils R; Hartmann A; Plass C; Wiemann S; Agaimy A
Nat Commun; 2019 Jan; 10(1):368. PubMed ID: 30664630
[TBL] [Abstract][Full Text] [Related]
34. Knockdown of long noncoding RNA AC245100.4 inhibits the tumorigenesis of prostate cancer cells via the STAT3/
Liu C; Lin P; Zhao J; Xie H; Li R; Yang X; Wang N; Jia H; Jiang S; Zhang K; Yu X
Epigenomics; 2021 Oct; 13(20):1591-1605. PubMed ID: 34657447
[TBL] [Abstract][Full Text] [Related]
35. The transcription factor NR4A3 controls CD103+ dendritic cell migration.
Park K; Mikulski Z; Seo GY; Andreyev AY; Marcovecchio P; Blatchley A; Kronenberg M; Hedrick CC
J Clin Invest; 2016 Dec; 126(12):4603-4615. PubMed ID: 27820700
[TBL] [Abstract][Full Text] [Related]
36. Bmi1 is a MYCN target gene that regulates tumorigenesis through repression of KIF1Bbeta and TSLC1 in neuroblastoma.
Ochiai H; Takenobu H; Nakagawa A; Yamaguchi Y; Kimura M; Ohira M; Okimoto Y; Fujimura Y; Koseki H; Kohno Y; Nakagawara A; Kamijo T
Oncogene; 2010 May; 29(18):2681-90. PubMed ID: 20190806
[TBL] [Abstract][Full Text] [Related]
37. β-Cell deletion of Nr4a1 and Nr4a3 nuclear receptors impedes mitochondrial respiration and insulin secretion.
Reynolds MS; Hancock CR; Ray JD; Kener KB; Draney C; Garland K; Hardman J; Bikman BT; Tessem JS
Am J Physiol Endocrinol Metab; 2016 Jul; 311(1):E186-201. PubMed ID: 27221116
[TBL] [Abstract][Full Text] [Related]
38. The MOC31PE immunotoxin reduces cell migration and induces gene expression and cell death in ovarian cancer cells.
Wiiger MT; Bideli H; Fodstad O; Flatmark K; Andersson Y
J Ovarian Res; 2014 Feb; 7():23. PubMed ID: 24528603
[TBL] [Abstract][Full Text] [Related]
39. Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma.
Eggert A; Ikegaki N; Liu XG; Brodeur GM
Klin Padiatr; 2000; 212(4):200-5. PubMed ID: 10994551
[TBL] [Abstract][Full Text] [Related]
40. The nuclear receptors NUR77, NURR1 and NOR1 in obesity and during fat loss.
Veum VL; Dankel SN; Gjerde J; Nielsen HJ; Solsvik MH; Haugen C; Christensen BJ; Hoang T; Fadnes DJ; Busch C; Våge V; Sagen JV; Mellgren G
Int J Obes (Lond); 2012 Sep; 36(9):1195-202. PubMed ID: 22143616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
